Acute respiratory distress syndrome: Underrecognition by clinicians and diagnostic accuracy of three clinical definitions

2007 ◽  
Vol 2007 ◽  
pp. 332-333
Author(s):  
J.A. Barker
Author(s):  
Claudia Brusasco ◽  
◽  
Gregorio Santori ◽  
Guido Tavazzi ◽  
Gabriele Via ◽  
...  

AbstractDiscriminating acute respiratory distress syndrome (ARDS) from acute cardiogenic pulmonary edema (CPE) may be challenging in critically ill patients. Aim of this study was to investigate if gray-level co-occurrence matrix (GLCM) analysis of lung ultrasound (LUS) images can differentiate ARDS from CPE. The study population consisted of critically ill patients admitted to intensive care unit (ICU) with acute respiratory failure and submitted to LUS and extravascular lung water monitoring, and of a healthy control group (HCG). A digital analysis of pleural line and subpleural space, based on the GLCM with second order statistical texture analysis, was tested. We prospectively evaluated 47 subjects: 16 with a clinical diagnosis of CPE, 8 of ARDS, and 23 healthy subjects. By comparing ARDS and CPE patients’ subgroups with HCG, the one-way ANOVA models found a statistical significance in 9 out of 11 GLCM textural features. Post-hoc pairwise comparisons found statistical significance within each matrix feature for ARDS vs. CPE and CPE vs. HCG (P ≤ 0.001 for all). For ARDS vs. HCG a statistical significance occurred only in two matrix features (correlation: P = 0.005; homogeneity: P = 0.048). The quantitative method proposed has shown high diagnostic accuracy in differentiating normal lung from ARDS or CPE, and good diagnostic accuracy in differentiating CPE and ARDS. Gray-level co-occurrence matrix analysis of LUS images has the potential to aid pulmonary edemas differential diagnosis.


2005 ◽  
Vol 33 (10) ◽  
pp. 2228-2234 ◽  
Author(s):  
Niall D. Ferguson ◽  
Fernando Frutos-Vivar ◽  
Andrés Esteban ◽  
Pilar Fernández-Segoviano ◽  
José Antonio Aramburu ◽  
...  

2020 ◽  
pp. 00504-2020
Author(s):  
Laura A. Hagens ◽  
Nanon F.L. Heijnen ◽  
Marry R. Smit ◽  
Marcus J. Schultz ◽  
Dennis C.J.J. Bergmans ◽  
...  

RationaleAcute Respiratory Distress Syndrome (ARDS) is currently diagnosed by the Berlin definition, which does not include a direct measure of pulmonary oedema, endothelial permeability or pulmonary inflammation. We hypothesised that biomarkers of these processes have good diagnostic accuracy for ARDS.MethodsMedline and Scopus were searched for original diagnostic studies using minimal invasive testing. Primary outcome was the diagnostic accuracy per test and categorised by control group. The methodological quality was assessed with Quadas-2 tool. Biomarkers that had an area under the Receiver Operating Characteristic curve (AUROCC) of more than 0.75 and were studied with minimal bias against an unselected control group were considered to be promising.ResultsForty-four articles were included. The median AUROCC for all evaluated tests was 0.80 (25th to 75th percentile: 0.72–0.88). The type of control group influenced the diagnostic accuracy (p=0.0095). Higher risk of bias was associated with higher diagnostic accuracy (AUROCC 0.75 for low bias, 0.77 for intermediate bias and 0.84 for high bias studies; p=0.0023). Club Cell protein 16 and soluble receptor for advanced glycation end-products in plasma and two panels with biomarkers of oxidative stress in breath showed good diagnostic accuracy in low bias studies that compared ARDS patients to an unselected intensive care unit (ICU) population.ConclusionThis systematic review revealed only four diagnostic tests fulfilling stringent criteria for a promising biomarker in a low bias setting. For implementation into the clinical setting, prospective studies in a general unselected ICU population with good methodological quality are needed.


2019 ◽  
Vol 47 (11) ◽  
pp. 1599-1606 ◽  
Author(s):  
Davide Chiumello ◽  
Michele Umbrello ◽  
Giuseppe Francesco Sferrazza Papa ◽  
Alessio Angileri ◽  
Martina Gurgitano ◽  
...  

2020 ◽  
Vol 49 (10) ◽  
pp. 418-421
Author(s):  
Christopher Werlein ◽  
Peter Braubach ◽  
Vincent Schmidt ◽  
Nicolas J. Dickgreber ◽  
Bruno Märkl ◽  
...  

ZUSAMMENFASSUNGDie aktuelle COVID-19-Pandemie verzeichnet mittlerweile über 18 Millionen Erkrankte und 680 000 Todesfälle weltweit. Für die hohe Variabilität sowohl der Schweregrade des klinischen Verlaufs als auch der Organmanifestationen fanden sich zunächst keine pathophysiologisch zufriedenstellenden Erklärungen. Bei schweren Krankheitsverläufen steht in der Regel eine pulmonale Symptomatik im Vordergrund, meist unter dem Bild eines „acute respiratory distress syndrome“ (ARDS). Darüber hinaus zeigen sich jedoch in unterschiedlicher Häufigkeit Organmanifestationen in Haut, Herz, Nieren, Gehirn und anderen viszeralen Organen, die v. a. durch eine Perfusionsstörung durch direkte oder indirekte Gefäßwandschädigung zu erklären sind. Daher wird COVID-19 als vaskuläre Multisystemerkrankung aufgefasst. Vor dem Hintergrund der multiplen Organmanifestationen sind klinisch-pathologische Obduktionen eine wichtige Grundlage der Entschlüsselung der Pathomechanismen von COVID-19 und auch ein Instrument zur Generierung und Hinterfragung innovativer Therapieansätze.


Sign in / Sign up

Export Citation Format

Share Document